What is BDD Pharma?
BDD Pharma is a UK-based contract research organization (CRO) and contract development and manufacturing organization (CDMO) with over 25 years of expertise in biopharmaceutics, oral drug formulation, and Phase 1 clinical trials. The company champions a Lean Clinical Development methodology, designed to expedite early-stage drug development timelines and reduce associated costs for its clients. Their comprehensive service portfolio includes formulation development, GMP manufacturing, and integrated clinical trial support, positioning them as a trusted partner for pharmaceutical innovators seeking tailored solutions and a collaborative approach to drug development.
How much funding has BDD Pharma raised?
BDD Pharma has raised a total of $2.5M across 1 funding round:
Other Financing Round
$2.5M
Other Financing Round (2023): $2.5M with participation from Archangels, Scottish Enterprise, and British Business Bank
Key Investors in BDD Pharma
Archangels
Archangels is an established architectural firm providing comprehensive services for residential, commercial, and institutional clients, known for thoughtful design and professional service.
Scottish Enterprise
Scottish Enterprise is dedicated to fostering economic growth in Scotland, focusing on creating quality jobs and improving regional prosperity through strategic initiatives.
British Business Bank
British Business Bank is a subsidiary focused on increasing credit availability for small and medium enterprises and providing business advisory services.
What's next for BDD Pharma?
The recent major enterprise-level funding indicates BDD Pharma is poised for significant scaling and expansion of its service offerings. This capital injection will likely fuel advancements in their Lean Clinical Development approach, potentially enabling broader adoption and further refinement of their integrated CRO/CDMO capabilities. Strategic investments of this magnitude typically signal an intent to enhance operational capacity, invest in new technologies, and potentially expand market reach, solidifying BDD Pharma's position in the competitive biopharmaceutical services landscape.
See full BDD Pharma company page
